Epalrestat
Epalrestat CAS82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat hutumiwa kuzuia, kuboresha, na kutibu ugonjwa wa neva wa pembeni (kufa ganzi, maumivu), paresthesia ya kutetemeka, na hali isiyo ya kawaida ya moyo inayohusiana na ugonjwa wa sukari. MAELEZO
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat hutumiwa kuzuia, kuboresha, na kutibu ugonjwa wa neva wa pembeni (kufa ganzi, maumivu), paresthesia ya kutetemeka, na hali isiyo ya kawaida ya moyo inayohusiana na ugonjwa wa sukari. MAELEZO
| P roduct jina | Epalrestat |
| CAS | 82159-09-9 |
| MF: | C15H13NO3S2 |
| MW: | 319.4 |
Andika ujumbe wako hapa na ututumie
